Heron Therapeutics Inc vs AT&T Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while AT&T Inc. trades at $24.42 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 2731.1× Heron Therapeutics Inc's market cap, and AT&T Inc. pays a 4.53% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | T | |
|---|---|---|
Market Cap | $61.47M | $167.88B |
Sector | Health | Media |
52-Week High | $1.49 | $29.62 |
52-Week Low | $0.32 | $20.49 |
Enterprise Value | $168.21M | $313.20B |
Dividend Yield | — | 4.53% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →